Ms. Ting Li Appointed to Biostage Board of Directors

HOLLISTON, Mass., Nov. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus, and trachea, today a... Regenerative Medicine, Personnel Biostage, bioengineered organ implant, Cellframe
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news